Your browser doesn't support javascript.
loading
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).
Younes, A; Hilden, P; Coiffier, B; Hagenbeek, A; Salles, G; Wilson, W; Seymour, J F; Kelly, K; Gribben, J; Pfreunschuh, M; Morschhauser, F; Schoder, H; Zelenetz, A D; Rademaker, J; Advani, R; Valente, N; Fortpied, C; Witzig, T E; Sehn, L H; Engert, A; Fisher, R I; Zinzani, P-L; Federico, M; Hutchings, M; Bollard, C; Trneny, M; Elsayed, Y A; Tobinai, K; Abramson, J S; Fowler, N; Goy, A; Smith, M; Ansell, S; Kuruvilla, J; Dreyling, M; Thieblemont, C; Little, R F; Aurer, I; Van Oers, M H J; Takeshita, K; Gopal, A; Rule, S; de Vos, S; Kloos, I; Kaminski, M S; Meignan, M; Schwartz, L H; Leonard, J P; Schuster, S J; Seshan, V E.
Afiliación
  • Younes A; Lymphoma Service.
  • Hilden P; Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, USA.
  • Coiffier B; Hematology, Université Lyon-1, Lyon-Sud Charles Mérieux, Lyon, France.
  • Hagenbeek A; Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Salles G; Hematology, Université Lyon-1, Lyon-Sud Charles Mérieux, Lyon, France.
  • Wilson W; Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, USA.
  • Seymour JF; Peter MacCallum Cancer Centre and University of Melbourne, Australia.
  • Kelly K; Pediatrics Department, Roswell-Park Cancer Institute, Buffalo, USA.
  • Gribben J; Department of Haemato-Oncology, Barts Cancer Institute, London, UK.
  • Pfreunschuh M; Department of Internal Medicine, Universität des Saarlandes, Homburg, Germany.
  • Morschhauser F; Department of Hematology, Université de Lille 2, Lille, France.
  • Schoder H; Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York.
  • Zelenetz AD; Lymphoma Service.
  • Rademaker J; Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York.
  • Advani R; Department of Oncology, Stanford University, Stanford.
  • Valente N; Genentech, San Francisco, USA.
  • Fortpied C; Statistics, EORTC, Brussels, Belgium.
  • Witzig TE; Mayo Clinic, Rochester, USA.
  • Sehn LH; British Columbia Cancer Agency, Vancouver, Canada.
  • Engert A; Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
  • Fisher RI; Fox Chase Cancer Center, Philadelphia, USA.
  • Zinzani PL; Department of Hematology, University of Bologna, Bologna.
  • Federico M; Department of Diagnostic Medicine, University of Modena, Modena, Italy.
  • Hutchings M; Department of Hematology, University of Copenhagen, Denmark.
  • Bollard C; Children's National Health System, Washington, USA.
  • Trneny M; Lymphoma and Stem Cell Transplantation Program, Charles University, Prague, Czech Republic.
  • Elsayed YA; Janssen Research & Development, Spring House, USA.
  • Tobinai K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Abramson JS; Massachusetts General Hospital, Center for Lymphoma, Boston.
  • Fowler N; U.T. M.D.Anderson Cancer Center, Houston.
  • Goy A; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack.
  • Smith M; Cleveland Clinic, Cleveland, USA.
  • Ansell S; Mayo Clinic, Rochester, USA.
  • Kuruvilla J; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Dreyling M; Medicine Clinic III, Ludwig Maximilian University, Munich, Germany.
  • Thieblemont C; Haemato-Oncology, Hôpital Saint Louis, Paris, France.
  • Little RF; Divisions of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, USA.
  • Aurer I; Department of Hematology, University Hospital Centre Zagreb, Zagreb, Croatia.
  • Van Oers MHJ; Academic Medical Center, Amsterdam, The Netherlands.
  • Takeshita K; Celgene, Summit.
  • Gopal A; Fred Hutchinson Cancer Research Center, Seattle, USA.
  • Rule S; Haematology Department, Plymouth University, UK.
  • de Vos S; Oncology, UCLA, Los Angeles, USA.
  • Kloos I; Servier, Neuilly sur Seine, France.
  • Kaminski MS; University of Michigan Comprehensive Cancer Center, Ann Arbor, USA.
  • Meignan M; Nuclear Medicine, Hôpitaux Universitaires Henri Mondor, Créteil, France.
  • Schwartz LH; Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York.
  • Leonard JP; Weill Cornell Medicine and and New York Presbyterian Hospital, New York.
  • Schuster SJ; University of Pennsylvania School of Medicine, Philadelphia, USA.
  • Seshan VE; Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, USA.
Ann Oncol ; 28(7): 1436-1447, 2017 Jul 01.
Article en En | MEDLINE | ID: mdl-28379322
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Tomografía Computarizada por Rayos X / Tomografía de Emisión de Positrones / Criterios de Evaluación de Respuesta en Tumores Sólidos / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Tomografía Computarizada por Rayos X / Tomografía de Emisión de Positrones / Criterios de Evaluación de Respuesta en Tumores Sólidos / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article